Healthcare
M&A Advisory
Technology
Pharmaceutical
Research
M&A Advisory
Lazard
Full Credential Description
Synta Pharmaceuticals. United States. Announced Date 08/01/2010. Closed Date 13/01/2010. Deal value: $25m. Underwritten registered direct offering of common stock. Industry: Synta Pharmaceuticals is a biopharmaceutical company focused on the research, development, and commercialization of novel oncology therapies.